Implantable photo-stimulation system for the treatment of Parkinson‟s disease

• Forschungsstelle: INNOSUISSE
• Projektnummer: 13758.1;9 PFFLE-LS
• Projekttitel Englisch: Implantable photo-stimulation system for the treatment of Parkinson‟s disease

Kurzbeschreibung (Englisch)

Implantable photo-stimulation system for the treatment of Parkinson‟s disease

Kurzbeschreibung (Französisch)

Implantable photo-stimulation system for the treatment of Parkinson's disease

Abstract (Englisch)

Numerous pre-clinical and clinical studies document the therapeutic effect of low level light therapy (LLLT) for the treatment of pain, inflammation, wounds, cardiovascular disorders and central nervous system disorders. There is a growing body of evidence that shows that LLLT modulates mitochondrial function and other metabolic processes. Parkinson‟s disease (PD) is a neurodegenerative disease characterized by abnormal mitochondrial function. Available treatment options only alleviate the symptoms of PD. Promising pre-clinical studies show the neuroprotective and neurogenerative potential of LLLT for the treatment of PD. The goal of this projects it to develop an implantable device for the treatment of PD and to collect pivotal pre-clinical data demonstrating the safety and efficacy of this novel therapy.

Abstract (Französisch)

Numerous pre-clinical and clinical studies document the therapeutic effect of low level light therapy (LLLT) for the treatment of pain, inflammation, wounds, cardiovascular disorders and central nervous system disorders. There is a growing body of evidence that shows that LLLT modulates mitochondrial function and other metabolic processes. Parkinson‟s disease (PD) is a neurodegenerative disease characterized by abnormal mitochondrial function. Available treatment options only alleviate the symptoms of PD. Promising pre-clinical studies show the neuroprotective and neurogenerative potential of LLLT for the treatment of PD. The goal of this projects it to develop an implantable device for the treatment of PD and to collect pivotal pre-clinical data demonstrating the safety and efficacy of this novel therapy.